KATHERINE BLANCO: Open Payments
NPI 1013771229 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 35 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $203 |
| ABBVIE INC. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Alkermes, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $63 |
| Lundbeck LLC | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Biogen, Inc. | 1 | $29 |
Products named: Azstarys, REXULTI, VRAYLAR, TRINTELLIX, CAPLYTA, Auvelity, ARISTADA, FANAPT.
Industry payments across FL — which companies pay providers there.
